留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

肝移植术后免疫耐受相关研究进展

许文犁 郎韧 李先亮 贺强

许文犁, 郎韧, 李先亮, 等. 肝移植术后免疫耐受相关研究进展[J]. 器官移植, 2019, 10(3): 278-282. doi: 10.3969/j.issn.1674-7445.2019.03.009
引用本文: 许文犁, 郎韧, 李先亮, 等. 肝移植术后免疫耐受相关研究进展[J]. 器官移植, 2019, 10(3): 278-282. doi: 10.3969/j.issn.1674-7445.2019.03.009
Xu Wenli, Lang Ren, Li Xianliang, et al. Research progress on immune tolerance after liver transplantation[J]. ORGAN TRANSPLANTATION, 2019, 10(3): 278-282. doi: 10.3969/j.issn.1674-7445.2019.03.009
Citation: Xu Wenli, Lang Ren, Li Xianliang, et al. Research progress on immune tolerance after liver transplantation[J]. ORGAN TRANSPLANTATION, 2019, 10(3): 278-282. doi: 10.3969/j.issn.1674-7445.2019.03.009

肝移植术后免疫耐受相关研究进展

doi: 10.3969/j.issn.1674-7445.2019.03.009
基金项目: 

国家自然科学基金 81571554

国家自然科学基金 81471590

国家自然科学基金 81273270

国家自然科学基金 81571825

详细信息
    作者简介:

    许文犁,男,1986年生,博士,主治医师,研究方向为肝移植与肝胆胰恶性肿瘤,Email:xuwlchaoyang@163.com

    贺强,医学博士,主任医师,教授,博士研究生导师。兼任中国医疗保健国际交流促进会肝脏移植分会主任委员、中华医学会器官移植学分会全国委员、中华医学会器官移植学分会肝移植学组委员、中华医学会外科学分会手术学组委员、中国医师协会器官移植医师分会委员、中国医师协会器官移植医师分会肝移植专业委员会委员、中国医药教育协会腹部肿瘤专业委员会委员,中国医疗保健国际交流促进会软组织肿瘤分会副主任委员、中国医疗保健国际交流促进会胰腺疾病分会委员、中国研究型医院学会移植医学专业委员会常务委员、中国研究型医院学会普通外科学专业委员会委员、北京医学会器官移植学分会常务委员、北京医师协会器官移植专家委员会委员、中国肝移植注册中心科学委员会委员。担任《器官移植》、《中华肝胆外科杂志》、《中华肝脏外科手术学电子杂志》《实用器官移植电子杂志》、《国际移植与血液净化杂志》、《肝癌电子杂志》、《国际外科学杂志》、《Journal of Organ Donation and Transplantation》等杂志编委。在国内外期刊发表学术论文百余篇,先后主持多项国家级及省部级科研课题。长期从事肝移植及肝胆胰肿瘤的临床与基础研究,在肝移植特别是重症肝病肝移植的围手术期管理方面具有丰富的临床经验。对肝胆胰肿瘤的综合诊治具有较深的造诣。擅长肝胆胰肿瘤的各种根治手术,尤其擅长联合血管切除异体血管移植的复杂疑难肝胆胰肿瘤手术以及体外肝切除自体肝移植手术

    通讯作者:

    李先亮,男,1971年生,博士,副主任医师,研究方向为肝移植与肝胆胰恶性肿瘤,Email:lixianliangbjcy@126.com

    贺强,男,1964年生,博士,主任医师,研究方向为肝移植与肝胆胰恶性肿瘤,Email:heqiang349@sina.com

  • 中图分类号: R617, R392.4

Research progress on immune tolerance after liver transplantation

  • 摘要: 肝移植是目前公认的治疗终末期肝病的最有效措施,而如何让移植受者获得免疫耐受状态则是肝移植科医师追求的最终目标。了解最新的国际多中心临床经验以及相关基础研究结果,有助于我们更深入地认识免疫耐受,从而为移植受者制定更加妥善的治疗方案。本文综合国际核心期刊报道的内容,从临床免疫耐受的可行性、免疫耐受的诱导和维持、免疫耐受诱导方案的制定及寻找合理的免疫状态的相关监测指标等方面作一综述,并对今后的研究方向作出展望。

     

  • [1] DEVLIN J, DOHERTY D, THOMSON L, et al. Defining the outcome of immunosuppression withdrawal after liver transplantation[J]. Hepatology, 1998, 27(4):926-933. doi: 10.1002/(ISSN)1527-3350
    [2] FENG S, EKONG UD, LOBRITTO SJ, et al. Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants[J]. JAMA, 2012, 307(3):283-293. DOI: 10.1001/jama.2011.2014.
    [3] DE LA GARZA RG, SAROBE P, MERINO J, et al. Trial of complete weaning from immunosuppression for liver transplant recipients: factors predictive of tolerance[J]. Liver Transpl, 2013, 19(9):937-944. DOI: 10.1002/lt.23686.
    [4] BRANCO JC, MORBEY A, MARTINS A, et al. Tolerance after liver transplantation: where are we?[J]. Liver Transpl, 2018, 24(9):1303-1304. DOI: 10.1002/lt.25294.
    [5] DEMETRIS AJ, BELLAMY CO, GANDHI CR, et al.Functional immune anatomy of the liver-as an allograft[J]. Am J Transplant, 2016, 16(6):1653-1680. DOI: 10.1111/ajt.13749.
    [6] NEUMANN K, RUDOLPH C, NEUMANN C, et al. Liver sinusoidal endothelial cells induce immunosuppressive IL-10-producing Th1 cells via the Notch pathway[J]. Eur J Immunol, 2015, 45(7):2008-2016. DOI: 10.1002/eji.201445346.
    [7] CHEN Y, XIE C, ZHENG X, et al. LIN28/let-7/PD-L1 pathway as a target for cancer immunotherapy[J]. Cancer Immunol Res, 2019, 7(3):487-497. DOI: 10.1158/2326-6066.CIR-18-0331.
    [8] KARIMI MH, GERAMIZADEH B, MALEK-HOSSEINI SA. Tolerance induction in liver[J]. Int J Organ Transplant Med, 2015, 6(2):45-54. doi: 10.1016-S1091-255X(02)00012-4/
    [9] LI L, WOZNIAK LJ, RODDER S, et al. A common peripheral blood gene set for diagnosis of operational tolerance in pediatric and adult liver transplantation[J]. Am J Transplant, 2012, 12(5):1218-1228. DOI: 10.1111/j.1600-6143.2011.03928.x.
    [10] HIGASHI T, FRIEDMAN SL, HOSHIDA Y. Hepatic stellate cells as key target in liver fibrosis[J]. Adv Drug Deliv Rev, 2017, 121:27-42. DOI: 10.1016/j.addr.2017.05.007.
    [11] THOMSON AW, EZZELARAB MB. Regulatory dendritic cells: profiling, targeting, and therapeutic application[J]. Curr Opin Organ Transplant, 2018, 23(5):538-545. DOI: 10.1097/MOT.0000000000000565.
    [12] MUCKSOVÁ J, PLACHÝ J, STANĚK O, et al. Cytokine response to the RSV antigen delivered by dendritic cell-directed vaccination in congenic chicken lines[J]. Vet Res, 2017, 48(1):18. DOI: 10.1186/s13567-017-0423-8.
    [13] LOTT DG, DAN O, LU L, et al. Decoy NF-kappaB fortified immature dendritic cells maintain laryngeal allograft integrity and provide enhancement of regulatory T cells[J]. Laryngoscope, 2010, 120(1):44-52. DOI: 10.1002/lary.20667.
    [14] CHATURVEDI V, COLLISON LW, GUY CS, et al. Cutting edge: human regulatory T cells require IL-35 to mediate suppression and infectious tolerance[J]. J Immunol, 2011, 186(12):6661-6666. DOI: 10.4049/jimmunol.1100315.
    [15] KNIGHT SR, MORRIS PJ. Steroid sparing protocols following nonrenal transplants; the evidence is not there. a systematic review and Meta-analysis[J]. Transpl Int, 2011, 24(12):1198-1207. DOI: 10.1111/j.1432-2277.2011.01335.x.
    [16] European Association for the Study of the Liver. EASL clinical practice guidelines: liver transplantation[J]. J Hepatol, 2016, 64(2):433-485. DOI: 10.1016/j.jhep.2015.10.006.
    [17] THIERRY A, LE MEUR Y, ECOTIÈRE L, et al. Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up study[J]. Transpl Int, 2016, 29(1):23-33. DOI: 10.1111/tri.12627.
    [18] YARYGIN KN, LUPATOV AY, SUKHIKH GT. Modulation of immune responses by mesenchymal stromal cells[J]. Bull Exp Biol Med, 2016, 161(4):561-565. DOI: 10.1007/s10517-016-3461-8.
    [19] LI XL, MÉNORET S, BEZIE S, et al. Mechanism and localization of CD8 regulatory T cells in a heart transplant model of tolerance[J]. J Immunol, 2010, 185(2):823-833. DOI: 10.4049/jimmunol.1000120.
    [20] TODO S, YAMASHITA K, GOTO R, et al. A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation[J]. Hepatology, 2016, 64(2):632-643. DOI: 10.1002/hep.8459.
    [21] ALEXOPOULOS SP, NEKRASOV V, CAO S, et al. Effects of recipient size and allograft type on pediatric liver transplantation for biliary atresia[J]. Liver Transpl, 2017, 23(2):221-233. DOI: 10.1002/lt.24675.
    [22] RUIZ P, MARTÍNEZ-PICOLA M, SANTANA M, et al. Torque teno virus is associated with the state of immune suppression early after liver transplantation[J]. Liver Transpl, 2019, 25(2):302-310. DOI: 10.1002/lt.25374.
    [23] RODRIGO E, LÓPEZ-HOYOS M, CORRAL M, et al. ImmuKnow as a diagnostic tool for predicting infection and acute rejection in adult liver transplant recipients: a systematic review and Meta-analysis[J]. Liver Transpl, 2012, 18(10):1245-1253. DOI: 10.1002/lt.23497.
  • 加载中
计量
  • 文章访问数:  308
  • HTML全文浏览量:  99
  • PDF下载量:  36
  • 被引次数: 0
出版历程
  • 收稿日期:  2019-02-20
  • 网络出版日期:  2021-01-19
  • 刊出日期:  2019-05-15

目录

    /

    返回文章
    返回